Advances in treatment and management: immunologic and cell-based regenerative therapies

Invest Ophthalmol Vis Sci. 2012 May 4;53(5):2511-4. doi: 10.1167/iovs.12-9483p.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Bone Marrow Cells
  • Fetal Blood / cytology
  • Glaucoma / therapy*
  • Humans
  • Neuroprotective Agents / administration & dosage
  • Ocular Hypertension / genetics
  • Ocular Hypertension / immunology
  • Optic Nerve Diseases / therapy*
  • Pluripotent Stem Cells / transplantation
  • Stem Cell Transplantation / methods*

Substances

  • Neuroprotective Agents